Page last updated: 2024-10-25

deferoxamine and Bang Disease

deferoxamine has been researched along with Bang Disease in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parent, MA1
Bellaire, BH1
Murphy, EA1
Roop, RM1
Elzer, PH1
Baldwin, CL1

Other Studies

1 other study available for deferoxamine and Bang Disease

ArticleYear
Brucella abortus siderophore 2,3-dihydroxybenzoic acid (DHBA) facilitates intracellular survival of the bacteria.
    Microbial pathogenesis, 2002, Volume: 32, Issue:5

    Topics: Animals; Brucella abortus; Brucellosis, Bovine; Cattle; Colony Count, Microbial; Deferoxamine; Hydro

2002